Alexander Marson

Internal Medicine

513 Parnassus Ave
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Host Genetic Regulation of NLRP3 Inflammasome Cytokines Reveals Immune and Vascular Pathways in HIV.

Host Genetic Regulation of NLRP3 Inflammasome Cytokines Reveals Immune and Vascular Pathways in HIV.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

Host Genetic Regulation of NLRP3 Inflammasome Cytokines Reveals Immune and Vascular Pathways in HIV.

Host Genetic Regulation of NLRP3 Inflammasome Cytokines Reveals Immune and Vascular Pathways in HIV.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits.

Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits.

Journal: Cell

Published: January 20, 2026

Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy.

Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy.

Journal: bioRxiv : the preprint server for biology

Published: December 25, 2025

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Journal: bioRxiv : the preprint server for biology

Published: December 19, 2025

Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function.

Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.

In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2025

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Journal: Nature biotechnology

Published: September 24, 2025

In vivo genome-wide CRISPR screens of human T cells in solid tumours.

In vivo genome-wide CRISPR screens of human T cells in solid tumours.

Journal: Nature

Published: July 20, 2025

Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells.

Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells.

Journal: Cell

Published: July 02, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026